Health Catalyst Inc. (HCAT)
NASDAQ: HCAT
· Real-Time Price · USD
4.00
0.05 (1.27%)
At close: May 01, 2025, 3:58 PM
1.27% (1D)
| Bid | 3.99 |
| Market Cap | 280.84M |
| Revenue (ttm) | 306.58M |
| Net Income (ttm) | -69.5M |
| EPS (ttm) | -1.15 |
| PE Ratio (ttm) | -3.48 |
| Forward PE | 9.28 |
| Analyst | Buy |
| Ask | 4 |
| Volume | 217,345 |
| Avg. Volume (20D) | 749,309 |
| Open | 4.01 |
| Previous Close | 3.95 |
| Day's Range | 3.92 - 4.05 |
| 52-Week Range | 3.56 - 9.24 |
| Beta | 1.44 |
About HCAT
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accuracy; population health management identifies improvement across the care continuum as well as actionable...
Sector Healthcare
IPO Date Jul 25, 2019
Employees 1,500
Stock Exchange NASDAQ
Ticker Symbol HCAT
Website https://www.healthcatalyst.com
Analyst Forecast
According to 11 analyst ratings, the average rating for HCAT stock is "Buy." The 12-month stock price forecast is $6.5, which is an increase of 62.50% from the latest price.
Stock ForecastsNext Earnings Release
Health Catalyst Inc. is scheduled to release its earnings on May 7, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
-11.13%
Health Catalyst shares are trading lower after the...
Unlock content with
Pro Subscription
5 months ago
+6.52%
Health Catalyst shares are trading higher after Citigroup maintained a Buy rating on the stock and raised its price target from $9 to $10.5.
